Sirona Biochem Corp.
SRBCF
$0.0418
$0.00010.24%
| Weiss Ratings | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Price History | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.13% | |||
| 30-Day Total Return | 3.98% | |||
| 60-Day Total Return | -19.62% | |||
| 90-Day Total Return | -8.13% | |||
| Year to Date Total Return | -8.13% | |||
| 1-Year Total Return | -30.33% | |||
| 2-Year Total Return | -39.68% | |||
| 3-Year Total Return | -73.88% | |||
| 5-Year Total Return | -82.29% | |||
| 52-Week High % Change | -38.53% | |||
| 52-Week Low % Change | 70.61% | |||
| Price | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.07 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Aug 02, 2024 | |||
| 52-Week High Price (Date) | Oct 01, 2024 | |||
| Valuation | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.99M | |||
| Enterprise Value | 13.28M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 11.76% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -4.31 | |||
| Enterprise Value/Revenue (TTM) | -1,114.00 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -7.99 | |||
| Enterprise Value/EBIT | -7.95 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 258.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 641 4466 | |||
| Address | 595 Burrard Street Vancouver, BC V7X 1L4 | |||
| Website | www.sironabiochem.com | |||
| Country | Canada | |||
| Year Founded | 2006 | |||
| Profitability | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14,010.92% | |||
| Profit Margin | 16,482.35% | |||
| Management Effectiveness | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -146.34% | |||
| Return on Equity | -- | |||
| Income Statement | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -11.90K | |||
| Total Revenue (TTM) | -11.90K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -35.50K | |||
| EBITDA (TTM) | -1.66M | |||
| EBIT (TTM) | -1.67M | |||
| Net Income (TTM) | -1.96M | |||
| Net Income Avl. to Common (TTM) | -1.96M | |||
| Total Revenue Growth (Q YOY) | -62.75% | |||
| Earnings Growth (Q YOY) | -64.06% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -56.25% | |||
| Balance Sheet | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 24.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 584.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.51M | |||
| Current Ratio (Q) | 0.340 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 585.80K | |||
| Total Current Liabilities (Q) | 1.72M | |||
| Total Debt (Q) | 2.40M | |||
| Total Liabilities (Q) | 3.09M | |||
| Total Common Equity (Q) | -2.51M | |||
| Cash Flow | SRBCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 1.17M | |||
| Net Change in Cash (TTM) | -205.30K | |||
| Levered Free Cash Flow (TTM) | -925.10K | |||
| Cash from Operations (TTM) | -1.49M | |||
